Allergan win bars Sandoz’s Lumigan generic

16-01-2014

Allergan win bars Sandoz’s Lumigan generic

Drug company Sandoz, the generic arm of Novartis, may not market generic versions of Allergan’s eye drop solution Lumigan before the last patent covering it expires in 2027, a district court decided on January 14.


Allergan, Sandoz, Lumigan, eye drops, glaucoma

LSIPR